Lipidio Pharma Overview

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 7

Lipidio Pharma General Information

Description

Developer of novel therapeutics intended for dermatological and metabolic diseases. The company's lead program is in clinical development for the treatment of multiple medical conditions, including dermatological conditions such as sebaceous hyperplasia and moderate to severe acne, as well as metabolic disorders such as nonalcoholic steatohepatitis and obesity, enabling healthcare professionals to treat skin-related medical needs.

Contact Information

Website
www.lipidiopharma.com
Formerly Known As
GDD Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3570 Carmel Mountain Road
  • Suite 200
  • San Diego, CA 92130
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 3570 Carmel Mountain Road
  • Suite 200
  • San Diego, CA 92130
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lipidio Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Secondary Transaction - Private Completed Clinical Trials - Phase 2
4. Early Stage VC (Series B) 10-Nov-2022 Cancelled Clinical Trials - Phase 2
3. Early Stage VC (Series A) 02-Nov-2022 Completed Clinical Trials - Phase 2
2. Accelerator/Incubator 01-Jan-2020 Completed Clinical Trials - Phase 2
1. Early Stage VC 10-Dec-2018 Completed Startup
To view Lipidio Pharma’s complete valuation and funding history, request access »

Lipidio Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Lipidio Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Lipidio Pharma Patents

  • 17

    Total Documents Applications and Grants

  • Total Patents Families

  • 11

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Lipidio Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4294517-A1 Methods for treating non-alcoholic steatohepatitis with a scd-1 inhibitor Pending 19-Feb-2021
EP-4294517-A4 Methods for treating non-alcoholic steatohepatitis with a scd-1 inhibitor Pending 19-Feb-2021
US-20240189275-A1 Methods for treating non-alcoholic steatohepatitis with a scd-1 inhibitor Pending 19-Feb-2021
WO-2022178261-A1 Methods for treating non-alcoholic steatohepatitis with a scd-1 inhibitor Inactive 19-Feb-2021
US-20240307388-A1 Formulations for substituted 3-pyrrolidines, compositions containing, and uses of same Inactive 06-Jun-2016 A61K31/501
To view Lipidio Pharma’s complete patent history, request access »

Lipidio Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Lipidio Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
3E Bioventures (China) Venture Capital Minority
Alethea Capital Management Venture Capital Minority
Angel (individual) Minority
FPWR Not-For-Profit Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Lipidio Pharma FAQs

  • Where is Lipidio Pharma headquartered?

    Lipidio Pharma is headquartered in San Diego, CA.

  • What is the size of Lipidio Pharma?

    Lipidio Pharma has 4 total employees.

  • What industry is Lipidio Pharma in?

    Lipidio Pharma’s primary industry is Drug Discovery.

  • Is Lipidio Pharma a private or public company?

    Lipidio Pharma is a Private company.

  • What is Lipidio Pharma’s current revenue?

    The current revenue for Lipidio Pharma is .

  • How much funding has Lipidio Pharma raised over time?

    Lipidio Pharma has raised $21.3M.

  • Who are Lipidio Pharma’s investors?

    3E Bioventures (China), Alethea Capital Management, , FPWR, and are 5 of 7 investors who have invested in Lipidio Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process